n-methylaspartate has been researched along with Devic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abhari, AP; Etemadifar, M; Rezaei, N; Yazdanpanah, N | 1 |
| Li, L; Liu, J; Tang, J; Wang, H; Zhou, L | 1 |
2 other study(ies) available for n-methylaspartate and Devic Disease
| Article | Year |
|---|---|
N-Methyl-D-Aspartate (NMDA)-Type Glutamate Receptors and Demyelinating Disorders: A Neuroimmune Perspective.
Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Glutamic Acid; Humans; N-Methylaspartate; Neuromyelitis Optica; Receptors, N-Methyl-D-Aspartate | 2022 |
Effects of C5a and Receptor CD88 on Glutamate and N-Methyl-D-Aspartic Acid Receptor Expression in the Mouse Model of Optic Neuromyelitis.
Topics: Animals; Disease Models, Animal; Glutamic Acid; Humans; Mice; Mice, Inbred C57BL; N-Methylaspartate; Neuromyelitis Optica; Receptor, Anaphylatoxin C5a; Spinal Cord Injuries | 2022 |